US at a glance
- Population
- 341.8 million 2025
- Life expectancy at birth
- 78.9 years, 2024
- People aged 65 and over
- 18.4 % of people, 2025
- Health spending per person
- 13,473 US$ per person, 2023
- Doctors
- 3.68 per 1,000 people, 2022
Updated
Reviewed by Chandani Patel
US Wastewater Surveillance Market Industry Trends and Forecast to 2034: Segmented by (Target, User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$193.3 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $228.6 Mn | — | — |
| 2025 (base) | $243.9 Mn | +$15.3 Mn | — |
| 2026 (forecast) | $260.2 Mn | +$16.3 Mn | +6.7% |
| 2027 (forecast) | $277.6 Mn | +$17.4 Mn | +13.8% |
| 2028 (forecast) | $296.2 Mn | +$18.6 Mn | +21.5% |
| 2029 (forecast) | $316.1 Mn | +$19.8 Mn | +29.6% |
| 2030 (forecast) | $337.3 Mn | +$21.2 Mn | +38.3% |
| 2031 (forecast) | $359.9 Mn | +$22.6 Mn | +47.6% |
| 2032 (forecast) | $384.0 Mn | +$24.1 Mn | +57.5% |
| 2033 (forecast) | $409.7 Mn | +$25.7 Mn | +68% |
| 2034 (forecast) | $437.1 Mn | +$27.4 Mn | +79.3% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $243.9 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $437.1 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 6.7% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Target and user (see all) |
| Key players | Biobot Analytics, Ginkgo Bioworks, Verily, GT Molecular, Kando (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Wastewater surveillance tests sewage for viruses and drugs to track disease trends in a community.
Key segments of the wastewater Surveillance market include target (SARS-CoV-2, Influenza and RSV and Polio) and user (Public Health Agencies, Utilities and Research).
Global health goals, donor and government funding, better mobile technology and focus on preventing disease are driving the wastewater Surveillance market.
Digital tools for community health, local manufacturing and public-private partnerships give the wastewater Surveillance market room to grow.
Limited budgets, weak health systems in some regions, workforce shortages and supply chain gaps hold back the wastewater Surveillance market.
The wastewater Surveillance market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).[1]
[1] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
Licensing, quality standards and payment models from public and private payers shape how wastewater Surveillance services are delivered and paid for in the US. Government health programs and insurance coverage are key to access.
What doctors and scientists are doing in Wastewater Surveillance right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 20 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 20 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.
From our blog
Medical Devices · US
Medical Devices · US
Pharmaceuticals · US
OTC & Nutraceuticals · US
Pharmaceuticals · US
Medical Devices · US